Back to Journals » Neuropsychiatric Disease and Treatment » Beneath the surface: genetic factors in schizophrenia
Neuropsychiatric Disease and Treatment
- View all (4657)
- Volume 22, 2026 (102)
- Volume 21, 2025 (221)
- Volume 20, 2024 (228)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Journal Articles:
- Addiction in the Digital Age: Emerging Challenges in Neuropsychiatry (1)
- Cognitive Enhancement in Psychiatric Disorders (1)
- Artificial Intelligence and Machine Learning in Neuropsychiatric Disease Diagnosis, Prognosis, and Treatment (1)
- Environmental Factors in Neuropsychiatric Pathophysiology and the Role of Alternative Therapeutic Approaches (1)
- Neuromodulation in Neuropsychiatric Disorders (1)
- Closing the Mortality Gap: Novel Approaches to Improve Physical Health and Quality of Life among People with Mental Illness (3)
- The effectiveness of non-pharmacological interventions for people with cognitive dysfunction (2)
- Advanced Neurorestoratology: Basic and Clinical Research (2)
- Autism, the disorder without borders and geopolitical variations (12)
- All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND) (1)
- Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective (2)
- Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke (1)
- Epileptic disorders: advances in the diagnostic and therapeutic strategies (3)
- Beneath the surface: genetic factors in schizophrenia (3)
- Stroke and neurorestoratology (1)
- Suicide Prevention and Intervention: Recent Evidence and Future Directions (4)
- Family and Peer Facilitated/Led Interventions for Severe Mental Health Problems (2)
- Therapeutic Response to Psychedelic Therapy – Who, What, Why & How? (3)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
- Issues and Solutions in Autism Spectrum Disorders (ASD) (9)
- Cariprazine in schizophrenia (5)
- The Caregiver Perspective on Pediatric ADHD (3)
- Volume 7 - Supplement 1 (5)
- Volume 6 - Supplement 1 (6)
Beneath the surface: genetic factors in schizophrenia
There are a multitude of potential reasons behind the onset of schizophrenia. While some may explain the condition through external factors, such as drug use or trauma, this Thematic Series considers the potential causes lying low beneath our own genetic material. It has been suggested that certain individuals could be predisposed to schizophrenia, potentially through family members or diathesis-stress models. Treatments therefore have the potential to be adapted to an individual based on genetics, as the influence of pharmacogenomics spreads further into neuropsychiatric illnesses. Therefore, genetics may be able to reveal answers about the origins of schizophrenia, but also the best treatment methods for patients.
Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP
Neuropsychiatric Disease and Treatment 2024, 20:923-936
Published Date: 3 May 2024
Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
Cao Y, Xu Y, Xia Q, Shan F, Liang J
Neuropsychiatric Disease and Treatment 2023, 19:1455-1462
Published Date: 23 June 2023
Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X, Wang L, Li S
Neuropsychiatric Disease and Treatment 2023, 19:2499-2509
Published Date: 20 November 2023
